SpringWorks Therapeutics, a pharmaceutical company in Baltimore’s Harbor East neighborhood, received the most venture capital among Maryland companies in 2017. Originally conceived by Pfizer, the company is focused on advancing potential programs for four diseases, all of which currently have no cure, including desmoid tumor, hereditary xerocytosis, neurofibromatosis and post-traumatic stress disorder. 2017 investors for the therapeutic development include Bain Capital, LifeArc, OrbiMed and Pfizer.…
from https://www.bizjournals.com/baltimore/news/2018/02/02/maryland-companies-received-most-venture-capital.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/170414406057
No comments:
Post a Comment